{
  "id": "58c0836102b8c6095300001c",
  "type": "yesno",
  "question": "Is there a relationship between B cells and Multiple Sclerosis?",
  "ideal_answer": "MS patients with high neurodegeneration have changes in B cells characterized by down-regulation of B-cell-specific genes and increased activation status",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/25267439",
    "http://www.ncbi.nlm.nih.gov/pubmed/19996075",
    "http://www.ncbi.nlm.nih.gov/pubmed/26857494",
    "http://www.ncbi.nlm.nih.gov/pubmed/26810546",
    "http://www.ncbi.nlm.nih.gov/pubmed/25666875",
    "http://www.ncbi.nlm.nih.gov/pubmed/26604134",
    "http://www.ncbi.nlm.nih.gov/pubmed/26732544",
    "http://www.ncbi.nlm.nih.gov/pubmed/20558389",
    "http://www.ncbi.nlm.nih.gov/pubmed/27120609",
    "http://www.ncbi.nlm.nih.gov/pubmed/24679343",
    "http://www.ncbi.nlm.nih.gov/pubmed/1839591",
    "http://www.ncbi.nlm.nih.gov/pubmed/25750917",
    "http://www.ncbi.nlm.nih.gov/pubmed/23634189",
    "http://www.ncbi.nlm.nih.gov/pubmed/18474519",
    "http://www.ncbi.nlm.nih.gov/pubmed/18388801",
    "http://www.ncbi.nlm.nih.gov/pubmed/18388800",
    "http://www.ncbi.nlm.nih.gov/pubmed/20970478",
    "http://www.ncbi.nlm.nih.gov/pubmed/24526661",
    "http://www.ncbi.nlm.nih.gov/pubmed/26724102",
    "http://www.ncbi.nlm.nih.gov/pubmed/18388796",
    "http://www.ncbi.nlm.nih.gov/pubmed/20535037",
    "http://www.ncbi.nlm.nih.gov/pubmed/25620021",
    "http://www.ncbi.nlm.nih.gov/pubmed/25895531",
    "http://www.ncbi.nlm.nih.gov/pubmed/21216828",
    "http://www.ncbi.nlm.nih.gov/pubmed/15800022"
  ],
  "snippets": [
    {
      "text": "These results suggest that RRMS patients with radiological phenotypes showing high neurodegeneration have changes in B cells characterized by down-regulation of B-cell-specific genes and increased activation status",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26604134",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Although the exact etiology is still obscure, the leading hypothesis behind MS relapses is acute inflammatory attacks on CNS myelin and axons. This complex process involves B and T cells together with macrophages and microglia.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25620021",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "It is currently known that CD24 serves as a costimulatory factor of T cells that regulate their homeostasis and proliferation, while in B cells, CD24 is functionally involved in cell activation and differentiation. CD24 can enhance autoimmune diseases in terms of its protective role in the clonal deletion of autoreactive thymocytes",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25666875",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Multiple B cell-dependent mechanisms contributing to inflammatory demyelination of the CNS have been explored using experimental autoimmune encephalomyelitis (EAE), a CD4 T cell-dependent animal model for multiple sclerosis. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25895531",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The role of B cells in multiple sclerosis: rationale for B-cell-targeted therapies.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18388801",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Interest in CD8+ T cells and B cells was initially inspired by observations in multiple sclerosis rather than in animal models: CD8+ T cells predominate in multiple sclerosis lesions, oligoclonal immunoglobulin bands in CSF have long been recognised as diagnostic and prognostic markers, and anti-B-cell therapies showed considerable efficacy in multiple sclerosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26724102",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Differential effects of fingolimod on B-cell populations in multiple sclerosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24526661",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Unaltered regulatory B-cell frequency and function in patients with multiple sclerosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25267439",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "B cells are increasingly recognized as major players in multiple sclerosis pathogenesis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18474519",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "These observations underscore the B cell's contribution to the putative underpinnings of multiple sclerosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26857494",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Data suggesting that B cells play a role in the pathogenesis of multiple sclerosis have been accumulating for the past five decades, demonstrating that the cerebrospinal fluid and central nervous system tissues of multiple sclerosis patients contain B cells, plasma cells, antibodies, and immunoglobulins.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18388801",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "B-cell-targeted treatment for multiple sclerosis: mechanism of action and clinical data.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18388796",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Subset composition and cytokine production of B cells derived from peripheral blood mononuclear cells from multiple sclerosis patients under Fingolimod treatment, untreated multiple sclerosis patients and healthy controls were analyzed by flow cytometry and ELISA.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25750917",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In particular, antigen presentation between B cells and T cells, increased trafficking of B cells across the blood-brain barrier, and autoantibodies produced by plasma cells may contribute to the pathophysiology of autoimmune disorders such as multiple sclerosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18388796",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Accumulating evidence supports a major role of B cells in multiple sclerosis (MS) pathogenesis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19996075",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Further research is needed to elucidate the pathology of B cells and their role in central nervous system autoimmune diseases, including multiple sclerosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18388800",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23634189",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "phingosine-1-phosphate receptors control B-cell migration through signaling components associated with primary immunodeficiencies, chronic lymphocytic leukemia, and multiple sclerosis",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24679343",
      "beginSection": "title",
      "endSection": "title"
    }
  ],
  "concepts": [
    "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001402",
    "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D009103",
    "http://www.disease-ontology.org/api/metadata/DOID:2377"
  ],
  "exact_answer": "Yes"
}